All news

Revolution Medicines executive sells shares under trading plan

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Revolution Medicines commercialization chief Anthony Mancini sold 811 shares for

Read original source

RVMD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.